Another Blood Pressure Medication Recalled

Two types of blood pressure drugs are now involved in the recall that began in late July over a suspected cancer-causing compound.

The recall of blood pressure medications continues and this time a new type of drug is involved.

In their latest announcement, Food and Drug Administration (FDA) officials said Solco Healthcare LLC has initiated a voluntary recall of one lot of Irbesartan and seven lots of Irbesartan HCTZ tablets.

The recall is due to the discovery of trace amounts of an unexpected impurity in a pharmaceutical ingredient known as N-nitrosodiethylamine (NDEA), which the FDA has classified as a "probable human carcinogen."

Company officials said there have been no adverse effects reported from people taking these pills.

In late December, Aurobindo Pharma USA Inc. announced it is taking off store shelves 80 lots of its Amlodipine Valsartan, Valsartan HCTZ, and Valsartan tablets.

www.khybertimes.ooo

from Latest News - SUCH TV http://bit.ly/2RFoTEZ

• Tweet
• Share
• Share
• Share
• Share